文献速递血液净化与透析

优化透析血管通路:超越「内瘘优先」策略

Optimizing Dialysis Vascular Access: Moving beyond Fistula First.
PubMed 文献 · Clin J Am Soc Nephrol · 2025-09-08

本文综述了「内瘘优先」策略的局限性,包括内瘘未成熟率高(30%-40%)、约半数需干预辅助成熟、且需辅助成熟的内瘘通畅期更短。意向性分析显示,对以中心静脉导管起始血液透析的患者,内瘘优先策略的年操作频率和总费用显著高于移植物。选择性策略对未成熟高风险患者优先使用移植物,可减少操作并降低费用,2019年KDOQI指南已体现这一理念。

要点

  • 内瘘未成熟率高达30%-40%,女性、老年及外周血管病患者更高
  • 约半数内瘘需手术或经皮干预辅助成熟,且后续通畅期更短
  • 对未成熟高风险患者选择性使用移植物可减少操作、降低费用

核心结论

  • 更精细化、以患者为中心的血管通路策略可能改善通路结局、减少操作负担并降低总体费用。

研究设计与样本

  • 本文为综述,未报告系统检索范围与样本量。

主要发现

  • 内瘘未成熟率为30%-40%,女性、老年及外周血管病患者中更高。
  • 约半数内瘘需手术或经皮干预辅助成熟,且需辅助成熟的内瘘通畅期更短、干预更频繁。
  • 意向性分析中,以中心静脉导管起始血液透析的患者遵循内瘘优先策略时,年通路操作频率和总费用显著高于移植物。
  • 晚期CKD患者透析前放置内瘘而非移植物时,以中心静脉导管起始透析更为常见。

关键数值与推荐

  • 2019年更新KDOQI血管通路指南推荐:在正确的时间为正确的患者、以正确的理由放置正确的通路。
  • 选择性策略:对AVF未成熟高风险患者,即使血管解剖适合AVF,也优先放置AVG。

临床怎么用

  • 对AVF未成熟高风险患者(如女性、老年、外周血管病),应选择性放置AVG而非一律追求AVF。
  • 决策时应权衡AVF未成熟风险、辅助成熟干预需求及通路管理总费用。

局限性

  • 本文为综述,未报告系统检索策略、纳入研究数量及偏倚评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

For many years, the vascular access guidelines recommended placement of arteriovenous fistulas (AVFs) in preference to arteriovenous grafts (AVGs) because AVFs had superior long-term patency, required fewer interventions to maintain patency, and were associated with lower costs of vascular access management. However, subsequent research has questioned the Fistula First strategy (placing an AVF whenever the vascular anatomy is suitable). First, AVF nonmaturation is substantial (30%-40%) and even higher among women, older patients, and those with peripheral vascular disease. Second, about half of AVFs require surgical or percutaneous interventions to assist maturation. Moreover, AVFs that require assisted maturation have shorter patency and require more frequent interventions, as compared with AVFs with unassisted maturation. Third, in an intent-to-treat analysis, when the Fistula First strategy is followed in patients initiating hemodialysis with a central venous catheter, the annual frequency of access procedures and the overall cost of access management are substantially greater for AVFs than AVGs. Fourth, in patients with advanced CKD undergoing predialysis access AVF rather than AVG placement, initiation of dialysis with a central venous catheter is much more common. An alternative strategy is a more selective one, in which patients at high risk of AVF nonmaturation preferentially receive an AVG, even if the vascular anatomy is suitable for an AVF. As compared with the Fistula First strategy, the more selective vascular access strategy is associated with fewer access procedures and a lower annual cost of access management. In summary, a more nuanced, patient-centered approach to vascular access may improve access outcomes, decrease the burden of access procedures, and lower the overall costs of vascular access management. This realization has been distilled in the 2019 updated Kidney Disease Outcomes Quality Initiative Vascular Access Guidelines, which exhort nephrologists and surgeons to place the right access in the right patient at the right time for the right reason.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Allon M, Young CJ, Lee T, et al. Optimizing Dialysis Vascular Access: Moving beyond Fistula First. Clin J Am Soc Nephrol. 2025. PMID: 40920483. doi:10.2215/CJN.0000000880

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。